491 related articles for article (PubMed ID: 25554371)
1. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
3. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
Tomlin AM; Lloyd HS; Tilyard MW
Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
[TBL] [Abstract][Full Text] [Related]
7. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
8. Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Rutten FH; Hak E; Stalman WA; Verheij TJ; Hoes AW
Fam Pract; 2003 Feb; 20(1):16-21. PubMed ID: 12509365
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
Hsu JC; Maddox TM; Kennedy K; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
J Am Coll Cardiol; 2016 Jun; 67(25):2913-23. PubMed ID: 27339487
[TBL] [Abstract][Full Text] [Related]
10. The treatment of paroxysmal atrial fibrillation in UK primary care.
Isaew A; Adderley NJ; Ryan R; Fitzmaurice D; Marshall T
Heart; 2017 Oct; 103(19):1502-1507. PubMed ID: 28572399
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.
Hansen ML; Jepsen RM; Olesen JB; Ruwald MH; Karasoy D; Gislason GH; Hansen J; Køber L; Husted S; Torp-Pedersen C
Europace; 2015 Jan; 17(1):18-23. PubMed ID: 25231909
[TBL] [Abstract][Full Text] [Related]
12. The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation.
Glauser TA; Barnes J; Nevins H; Cerenzia W
Am J Med Qual; 2016; 31(1):38-46. PubMed ID: 25115364
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING).
Pipilis A; Farmakis D; Kaliambakos S; Antoniou A; Goudevenos J; Lekakis J;
Int J Cardiol; 2014 Aug; 175(3):569-70. PubMed ID: 24874899
[No Abstract] [Full Text] [Related]
17. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
[TBL] [Abstract][Full Text] [Related]
18. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
Wolff A; Shantsila E; Lip GY; Lane DA
Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
20. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL
Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
